skip to main content
Close Icon We use cookies to improve your website experience.  To learn about our use of cookies and how you can manage your cookie settings, please see our Cookie Policy.  By continuing to use the website, you consent to our use of cookies.
Global Search Configuration
  • Close Icon

Stay on top of the rapidly accelerating complexity of oncology drug development with more crucial cancer drug insights from In Vivo –  Success in Oncology, is now available for you to download.


In this free In Vivo Success in Oncology mini-magazine, you will discover:

  • How biopharma companies must transform their portfolios and partnerships, adapt more dynamic business and operating models and decision-making processes to stay apace of the new complexities of the cancer drugs market.
  • An interview with Bayer AG’s EVP of their new Oncology Strategic Business Unit, who discusses how the German conglomerate sees oncology drugs as a key engine of future success within its high growth pharmaceuticals business.
  • Profiles of Ambrx and Sutro Biopharma, two smaller biotechs with promising technologies and powerful partners who augment strong science with disease awareness, deep commercial networks, and global geographic reach.





電話:+81 (0)3 6273 4260